11
TÍTULO: Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma
AUTORES: Katja Weisel; Meletios Dimopoulos; Philippe Moreau; Munci Yagci; Alessandra Larocca; Abraham S Kanate; Filiz Vural; Nicola Cascavilla; Supratik Basu; Peter Johnson; Peter Byeff; Marek Hus; Paula Rodriguez Otero; Ercan Muelduer; Pekka Anttila; Patrick J Hayden; Maria Theresa Krauth; Paulo Lucio; Dina Ben Yehuda; Larisa Mendeleeva; Shien E Guo; Xin Yu; Lara Grote; Tsvetan Biyukov; Sujith Dhanasiri; Paul Richardson; ...Mais
PUBLICAÇÃO: 2020, FONTE: LEUKEMIA & LYMPHOMA
INDEXADO EM: WOS
12
TÍTULO: Outcomes of patients with t(11;14) multiple myeloma: An International Myeloma Working Group (IMWG) multicenter study.
AUTORES: Brian G Durie; Hartmut Goldschmidt; Maria Victoria Mateos; Veronica Gonzalez; Juan Du; Kihyun Kim; Giampaolo Merlini; Silvia Mangiacavalli; Chang Ki Min; Meletios A Dimopoulos; Efstathios Kastritis; Heinz Ludwig; Graca Esteves; Hiroshi Handa; Fernando Escalante; Carlos Fernandez D de Larrea Rodriguez; Michel Delforge; Chris Cameron; Vincent V Rajkumar; Shaji Kumar;
PUBLICAÇÃO: 2019, FONTE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 37, NÚMERO: 15
INDEXADO EM: WOS
13
TÍTULO: Insights on Multiple Myeloma Treatment Strategies
AUTORES: Maria Victoria Mateos; Heinz Ludwig; Ali Bazarbachi; Meral Beksac; Joan Blade; Mario Boccadoro; Michele Cavo; Michel Delforge; Meletios A Dimopoulos; Thierry Facon; Catarina Geraldes; Hartmut Goldschmidt; Roman Hajek; Markus Hansson; Krzysztof Jamroziak; Merav Leiba; Tames Masszi; Larisa Mendeleeva; Michael O'Dwyer; Torben Plesner; Jesus F San Miguel; Christian Straka; Niels W C J van de Donk; Kwee Yong; Samo Zver; Philippe Moreau; Pieter Sonneveld; ...Mais
PUBLICAÇÃO: 2019, FONTE: HEMASPHERE, VOLUME: 3, NÚMERO: 1
INDEXADO EM: Scopus WOS
14
TÍTULO: Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma
AUTORES: Thierry Facon; Meletios A Dimopoulos; Angela Dispenzieri; John V Catalano; Andrew Belch; Michele Cavo; Antonello Pinto; Katja Weisel; Heinz Ludwig; Nizar J Bahlis; Anne Banos; Mourad Tiab; Michel Delforge; Jamie D Cavenagh; Catarina Geraldes; Je Jung Lee; Christine Chen; Albert Oriol; Javier De La Rubia; Darrell White; Daniel Binder; Jin Lu; Kenneth C Anderson; Philippe Moreau; Michel Attal; Aurore Perrot; Bertrand Arnulf; Lugui G Qiu; Murielle Roussel; Eileen Boyle; Salomon Manier; Mohamad Mohty; Herve Avet Loiseau; Xavier Leleu; Annette Ervin Haynes; Guang Chen; Vanessa Houck; Lotfi Benboubker; Cyrille Hulin; ...Mais
PUBLICAÇÃO: 2018, FONTE: BLOOD, VOLUME: 131, NÚMERO: 3
INDEXADO EM: WOS
15
TÍTULO: One-Year Update of a Phase 3 Randomized Study of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) in Patients (Pts) with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM): Alcyone
AUTORES: Meletios A Dimopoulos; Maria Victoria Mateos; Michele Cavo; Kenshi Suzuki; Andrzej Jakubowiak; Stefan Knop; Chantal Doyen; Paulo Lucio; Zsolt Nagy; Polina Kaplan; Ludek Pour; Mark Cook; Sebastian Grosicki; Andre H Crepaldi; Anna Marina Liberati; Philip Campbell; Tatiana Shelekhova; Sung Soo Yoon; Genadi Iosava; Tomoaki Fujisaki; Mamta Garg; Christopher Chiu; Jianping P Wang; Anupa Kudva; Rachel Kobos; Susan Wroblewski; Ming Qi; Jesus F San Miguel; Joan Blade; ...Mais
PUBLICAÇÃO: 2018, FONTE: 60th Annual Meeting of the American-Society-of-Hematology (ASH) in BLOOD, VOLUME: 132
INDEXADO EM: WOS
16
TÍTULO: A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation
AUTORES: Katja Weisela; Chantal Doyen; Meletios Dimopoulos; Adrian Yee; Juan J Jose Lahuerta; Amber Martin; Karin Travers; Eric Druyts; Kabirraaj Toor; Niels Abildgaard; Jin Lu; Jan Van Droogenbroeck; Catarina Geraldes; Mario Petrini; Laurent Voillat; Eric Voog; Thierry Facon;
PUBLICAÇÃO: 2017, FONTE: LEUKEMIA & LYMPHOMA, VOLUME: 58, NÚMERO: 1
INDEXADO EM: WOS
17
TÍTULO: FINAL ANALYSIS OF GLOBAL SURVIVAL OF THE FIRST TEST IN PATIENTS WITH MULTIPLE NEW DIAGNOSTIC MYELOMA  Full Text
AUTORES: Oriol, A; Facon, T; Dimopoulos, M; Dispenzieri, A; Cavo, M; Weisel, K; Ludwig, H; Delforge, M; Geraldes, C; Lee, JJ; Chen, C; De La Rubia, J; White, D; Binder, D; Lu, J; Anderson A Kenneth; Moreau, P; Attal, M; Fermand, JP; Avet A Loiseau; Ervin E Haynes; Chen, G; Houck, V; Hulin, C; Benboubker, L; ...Mais
PUBLICAÇÃO: 2017, FONTE: 59th National Congress of the Spanish-Society-of-Hematology-and-Hemotherapy in HAEMATOLOGICA, VOLUME: 102
INDEXADO EM: WOS
18
TÍTULO: Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial
AUTORES: Cyrille Hulin; Andrew Belch; Chaim Shustik; Maria Teresa Petrucci; Ulrich Duehrsen; Jin Lu; Kevin Song; Philippe Rodon; Brigitte Pegourie; Laurent Garderet; Hannah Hunter; Isabelle Azais; Richard Eek; Heinz Gisslinger; Margaret Macro; Shaker Dakhil; Cristina Goncalves; Richard LeBlanc; Ken Romeril; Bruno Royer; Chantal Doyen; Xavier Leleu; Fritz Offner; Nicolas Leupin; Vanessa Houck; Guang Chen; Annette Ervin Haynes; Meletios A Dimopoulos; Thierry Facon; ...Mais
PUBLICAÇÃO: 2016, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 34, NÚMERO: 30
INDEXADO EM: Scopus WOS
19
TÍTULO: Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma
AUTORES: Lotfi Benboubker; Meletios A Dimopoulos; Angela Dispenzieri; John Catalano; Andrew R Belch; Michele Cavo; Antonello Pinto; Katja Weisel; Heinz Ludwig; Nizar Bahlis; Anne Banos; Mourad Tiab; Michel Delforge; Jamie Cavenagh; Catarina Geraldes; Je Jung Lee; Christine Chen; Albert Oriol; Javier de la Rubia; Lugui G Qiu; Darrell J White; Daniel Binder; Kenneth Anderson; Jean Paul Fermand; Philippe Moreau; Michel Attal; Robert Knight; Guang Chen; Jason Van Oostendorp; Christian Jacques; Annette Ervin Haynes; Herve Avet Loiseau; Cyrille Hulin; Thierry Facon; ...Mais
PUBLICAÇÃO: 2014, FONTE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 371, NÚMERO: 10
INDEXADO EM: Scopus WOS CrossRef
20
TÍTULO: LENALIDOMIDE plus LOW-DOSE DEXAMETHASONE (RD) VS. MELPHALAN-PREDNISONE-THALIDOMIDE (MPT) IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) PATIENTS (PTS): THE FIRST TRIAL  Full Text
AUTORES: Facon, T; Dimopoulos, MA; Dispenzieri, A; Catalano, JV; Belch, A; Hulin, C; Cavo, M; Pinto, A; Weisel, KC; Ludwig, H; Bahlis, N; Banos, A; Tiab, M; Delforge, M; Cavenagh, J; Geraldes, C; Lee, JJ; Chen, C; Oriol, A; De La Rubia, J; Qiu, L; White, D; Binder, D; Anderson, KC; Moreau, P; Attal, M; Knight, R; Chen, G; Van Oostendorp, J; Jacques, CJ; Ervin Haynes, A; Benboubker, L; ...Mais
PUBLICAÇÃO: 2014, FONTE: 19th Congress of the European-Hematology-Association in HAEMATOLOGICA, VOLUME: 99
INDEXADO EM: WOS
Página 2 de 3. Total de resultados: 26.